Inflazome Limited
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 15, 2027The maintenance fee for Novel Processes (US 11,724,988) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 1 fee due Apr 3, 2027The maintenance fee for Sulfonamide Carboxamide Compounds (US 11,773,058) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
- 1 fee due Jun 5, 2027The maintenance fee for Novel Compounds (US 11,834,433) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Sulfonyl Acetamides as NLRP3 Inhibitors (US 11,884,645) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 1 fee due Aug 20, 2027The maintenance fee for Novel Compounds (US 11,905,252) comes due Aug 20, 2027. Unpaid by Feb 22, 2028, it lapses early.
- 1 fee due Sep 12, 2027The maintenance fee for Sulfonylureas and Sulfonylthioureas as NLRP3 Inhibitors (US 11,926,600) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 1 fee due Nov 14, 2027The maintenance fee for Novel Sulfonamide Carboxamide Compounds (US 11,981,667) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,465,992 | Novel Sulfonamide Carboxamide Compounds In force · High confidence | In force | High confidence | |
| US 11,981,667 | Novel Sulfonamide Carboxamide Compounds In force · Medium confidence | In force | Medium confidence | |
| US 11,518,739 | Sulfonamide Carboxamide Compounds In force · High confidence | In force | High confidence | |
| US 11,542,255 | Sulfonylureas and Sulfonylthioureas as NLRP3 Inhibitors In force · High confidence | In force | High confidence | |
| US 11,613,542 | Sulfonylureas and Sulfonylthioureas as NLRP3 Inhibitors In force · High confidence | In force | High confidence | |
| US 11,773,058 | Sulfonamide Carboxamide Compounds In force · High confidence | In force | High confidence | |
| US 11,926,600 | Sulfonylureas and Sulfonylthioureas as NLRP3 Inhibitors In force · High confidence | In force | High confidence | |
| US 12,012,392 | Novel Sulfonamide Carboxamide Compounds In force · High confidence | In force | High confidence | |
| US 12,221,434 | Sulfonamide Carboxamide Compounds In force · High confidence | In force | High confidence | |
| US 11,623,922 | Novel Compounds In force · High confidence | In force | High confidence |
Also on record, not counted in the 19: 2 patents in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 13 abandoned · 7 no status recorded